In celebration of two important milestones in the field of nucleic acids, this Virtual Special Issue aims to provide a platform for the scientific community to present their high-quality research on all topics relating to nucleic acids. Submit your work by July 31, 2023.

digital illustration of DNA

The year 2023 marks two important milestones in the field of nucleic acids research. It marks both the 101st anniversary of the birth of Har Gobind Khorana and the 70th year of the publication of the double-helical structure of Deoxyribose Nucleic Acid by James Watson and Francis Crick.

The elucidation of the double-helical structure of DNA by James Watson and Francis Crick in 1953, along with the key contribution by Maurice Wilkins and Rosalind Franklin, is widely regarded as one of the most significant scientific breakthroughs of the 20th century. For this, Watson, Crick and Wilkins shared Nobel Prize in 1962. This discovery revolutionized the field of biology by revealing how genetic information is stored, replicated, and transmitted from generation to generation, and laying the foundation for the development of modern genetics and biotechnology.

Har Gobind Khorana shared the 1968 Nobel Prize for Physiology or Medicine with Marshall W. Nirenberg and Robert W. Holley for his research on the genetic code and its interpretation by cells. In subsequent years, he developed his understanding even further by deciphering the genetic code by synthesizing RNA fragments of a known sequence and determining the corresponding amino acid sequence of the protein they encoded. Khorana's pioneering work on the genetic code and its deciphering laid the foundation for the development of modern biotechnology and genetic engineering, and his contributions have had a profound impact on our understanding of the fundamental principles of life.

This Virtual Special Issue from ACS Omega aims to provide a platform for the scientific community to present their high-quality research in nucleic acids, in celebration of this milestone anniversary.

We invite Articles, Mini-Reviews, Reviews, or Perspectives on all topics relating to nucleic acids, including (but not limited to):

  • Nucleic acid structure and dynamics
  • DNA/RNA analogues - structure and synthesis
  • Antisense/siRNA/miRNA/mRNA/gene-editing applications
  • Synthetic process developments
  • DNA/RNA self-assembly and nanomaterials
  • DNA-small molecule/protein interactions and
  • Gene editing and regulation

Guest Editors

Dr. Muthiah (Mano) Manoharan, Alnylam Pharmaceuticals, USA

Prof. Krishna Ganesh, IISER Tirupati, India

Submission Information

We welcome submissions for this Virtual Special Issue through July 31, 2023. All manuscripts will be peer-reviewed to ensure they fit the scope and conform to the high-quality scientific standards of ACS Omega prior to acceptance.

If your paper is accepted, your work will be highlighted as a significant contribution to this growing field of exploration. As ACS Omega is a fully open access journal, your paper will be available to anyone, at anytime, anywhere in the world.

Accepted publications will go online as soon as possible after acceptance and be published in the next available issue. In the Fall of 2023, the publications on this topic will be gathered into a Virtual Special Issue on a dedicated webpage and be promoted as a collection.

Article Processing Charges apply for publication in this fully open access journal. Please see our website for more information on Open Access Pricing, our ACS Country Discount & Waiver Policy, and ACS Read + Publish agreements.

How to Submit

Please see ACS Omega's Author Guidelines for more information on submission requirements. The deadline for submissions is July 31, 2023.

If you have any general questions regarding submission to this Virtual Special Issue, please contact Professor Krishna Ganesh.

Want More from This Journal?
ACS Omega Journal Cover

Stay Connected

Sign up today for email updates on the latest research, issues, and other content from ACS Omega.

Want the latest stories delivered to your inbox each month?